Schering-Plough Corporation (Jobs) Pulls EU Antibiotic Filing

July 26, 2007 |

1 min read

LONDON, July 26 (Reuters) - U.S. drugmaker Schering-Plough Corp. (SGP.N: Quote, Profile, Research) has withdrawn its application to European regulators for experimental antibiotic garenoxacin, the European Medicines Agency said on Thursday.

Regulatory Europe

MORE ON THIS TOPIC

Business competitive advantage of paper plane in new competitive, competitor individual pointing in different ways for new competitive advantage on 3D render. Advantage for new idea competition.

Insights

Denmark’s foundation‑fueled biotech boom redraws the Nordic map

July 27, 2026

·

4 min read

·

Jennifer C. Smith-Parker

Chess made from China and EU, USA flags. Europe Union, USA and China relations

China

Summit, Merck must navigate new regulatory terrain in China-first cancer landscape

July 27, 2026

·

10 min read

·

Heather McKenzie

A crowd of abstract multicolored silhouettes of people and conversational bubbles above them, made in the style of a collage. A metaphor for society and cooperation.

Regulatory

Amgen deploys patients to defend troubled Tavneos in FDA hearing request

July 24, 2026

·

4 min read

·

Annalee Armstrong

Winter season driving tips and traffic regulation rules. Heavy snow covered "snow and ice" road sign. Close-up view. Flat vector illustration template.

Complete response letters

Update: FDA does not freeze CRL trove as ‘radical transparency’ push hits speedbump

July 23, 2026

·

3 min read

·

Tristan Manalac